Susan Moran - Jan 22, 2024 Form 4 Insider Report for RayzeBio, Inc. (RYZB)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jeff Woodley, Attorney-in-Fact
Stock symbol
RYZB
Transactions as of
Jan 22, 2024
Transactions value $
$100,035
Form type
4
Date filed
2/6/2024, 06:11 PM
Previous filing
Nov 17, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYZB Common Stock Options Exercise $100K +30.9K +10.58% $3.24* 323K Jan 22, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYZB Employee Stock Option (right to buy) Options Exercise $0 -30.9K -33.69% $0.00 60.8K Jan 22, 2024 Common Stock 30.9K $3.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares vested on September 29, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.